福建省闽东力捷迅药业股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
106
NMPA:106
Drug Approvals
Roxatidine Acetate Hydrochloride for Injection
- Product Name
- 注射用盐酸罗沙替丁醋酸酯
- Approval Number
- 国药准字H20253570
- Approval Date
- Mar 11, 2025
NMPA
Oseltamivir Phosphate Capsules
- Product Name
- 磷酸奥司他韦胶囊
- Approval Number
- 国药准字H20253124
- Approval Date
- Jan 8, 2025
NMPA
Potassium Sodium Dehydroandrographolide Succinate
- Product Name
- 炎琥宁
- Approval Number
- 国药准字H20053796
- Approval Date
- Dec 23, 2024
NMPA
Troxerutin for Injection
- Product Name
- 注射用曲克芦丁
- Approval Number
- 国药准字H20050694
- Approval Date
- Sep 23, 2024
NMPA
Omeprazole Enteric-coated Capsules
- Product Name
- 奥美拉唑肠溶胶囊
- Approval Number
- 国药准字H20094004
- Approval Date
- Sep 23, 2024
NMPA
Vortioxetine Hydrobromide Tablets
- Product Name
- 氢溴酸伏硫西汀片
- Approval Number
- 国药准字H20244342
- Approval Date
- Jun 28, 2024
NMPA
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution
- Product Name
- 氨溴特罗口服溶液
- Approval Number
- 国药准字H20243239
- Approval Date
- Feb 23, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 11
- Next
Clinical Trials
No trials found
News
No news found